Outcome measure | Pearson’s correlation coefficient | P value |
mRSS | 0.56 | <0.001 |
mRSS upper limbs | 0.58 | <0.001 |
SHAQ (disease index) | 0.38 | <0.001 |
SHAQ VAS scores | ||
VAS pain | 0.28 | 0.107 |
VAS GI | 0.10 | 0.239 |
VAS breathing | 0.17 | 0.236 |
VAS RP | 0.16 | 0.406 |
VAS DU | 0.26 | 0.466 |
VAS limitations | 0.32 | 0.026 |
SFS | 0.25 | 0.011 |
SSPRO | 0.60 | <0.001 |
SSPRO subdomains | ||
Physical effects | 0.59 | <0.001 |
Physical limitations | 0.62 | <0.001 |
Emotional effects | 0.48 | <0.001 |
Social effects | 0.42 | <0.001 |
DU, digital ulcers; GI, gastrointestinal; mRSS, modified Rodnan Skin Score; PASTUL, Patient Self-Assessment of Skin Thickness in Upper Limb; RP, Raynaud’s phenomenon; SFS, Scleroderma Functional Score; SHAQ, Scleroderma Health Assessment Questionnaire; SSPRO, Scleroderma Skin Patient-Reported Outcome; VAS, Visual Analogue Score.